PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-3.40
Negative P/E while Healthcare median is -1.14. Seth Klarman would scrutinize path to profitability versus peers.
5.49
P/S near Healthcare median of 5.49. Charlie Munger would examine if similar pricing reflects similar economics.
0.33
P/B less than half the Healthcare median of 2.47. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-28.46
Negative FCF while Healthcare median P/FCF is -4.47. Seth Klarman would investigate cash flow improvement potential.
-28.46
Negative operating cash flow while Healthcare median P/OCF is -3.99. Seth Klarman would investigate operational improvement potential.
0.33
Fair value ratio less than half the Healthcare median of 2.48. Joel Greenblatt would investigate if this discount is justified.
-7.36%
Negative earnings while Healthcare median yield is -2.63%. Seth Klarman would investigate path to profitability.
-3.51%
Negative FCF while Healthcare median yield is -3.05%. Seth Klarman would investigate cash flow improvement potential.